Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Ezetimibe/simvastatin combination improves clinical efficacy in ACS patients

March 19, 2015

Kyushu University and Tokyo Medical University patent MFG-E8 compositions

March 17, 2015

Mezzion plans phase III studies of udenafil for adolescents with a single functional ventricle

March 17, 2015

Bendavia fails to reduce infarct size in first-time STEMI patients

March 16, 2015

Novartis's LCZ-696 awarded priority review by Health Canada

March 13, 2015

Quantum Genomics initiates phase IIa trial of QGC-001 for hypertension

March 6, 2015

Pulmokine secures funding for phase I trial of PDGF receptor kinase inhibitor PK-10571

March 4, 2015

Mast Therapeutics reports data from nonclinical study of vepoloxamer in advanced heart failure

March 4, 2015

Merck Patent discloses new fatty acid synthase inhibitors

March 2, 2015

Merck & Co. patents new ROMK channel blockers

Feb. 24, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...